Selank: Unpacking the Russian Peptide's Anxiolytic, Nootropic, and Immunomodulatory Mechanisms

Selank is a synthetic heptapeptide developed at the Russian Academy of Sciences and approved in Russia since 2009 for anxiety and neurasthenia. Unlike benzodiazepines, it modulates GABAA receptors without causing sedation or dependence, while simultaneously upregulating BDNF and modulating 34 immunerelated genes — making it one of the most pharmacologically multifaceted nootropic peptides in research.

For research use only. Not for human consumption.